Dr. Robert Schwartz is a independent physician scientist investigator in the fields of biomedical engineering, stem cell biology, regenerative medicine, and virology is to build and translate ideas and discoveries in the laboratory to the clinic. My work has led to 116 publications. My group was the first group to leverage human stem cell-based cell or tissue platforms for the study of infectious disease and we have shown that it can be leveraged to study a variety of different pathogen infections. I have focused on its use in hepatotropic pathogens (hepatitis B and C viral infection and plasmodium falcipirum), neurotropic pathogens (Zika virus, CMV, and HSV), and respiratory pathogens including SARS-CoV-2. We have also leveraged these platforms to study metabolic diseases such as MASLD/MASH and as tools to study hepatocarcinogenesis in diseases such as hepatoblastoma.